(S)-amphetamine decreases expression ISO RGD:10206 6480464 Dextroamphetamine results in decreased expression of ATP1A2 mRNA CTD PMID:12558987 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of ATP1A2 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ATP1A2 mRNA CTD PMID:15834898 more ... 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ATP1A2 mRNA CTD PMID:20170705 , PMID:26865667 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ATP1A2 mRNA CTD PMID:26945725 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736008 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP1A2 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10206 6480464 Tetrachlorodibenzodioxin affects the expression of ATP1A2 mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10206 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ATP1A2 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736008 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ATP1A2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:10206 6480464 bis4-hydroxyphenylsulfone results in increased expression of ATP1A2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:10206 6480464 Fenretinide results in decreased expression of ATP1A2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:736008 6480464 Decitabine affects the expression of ATP1A2 mRNA CTD PMID:23300844 aflatoxin B1 affects expression ISO RGD:736008 6480464 Aflatoxin B1 affects the expression of ATP1A2 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:736008 6480464 Aflatoxin B1 results in decreased methylation of ATP1A2 exon CTD PMID:30157460 aflatoxin B1 increases methylation ISO RGD:736008 6480464 Aflatoxin B1 results in increased methylation of ATP1A2 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:736008 6480464 Aflatoxin B1 results in decreased expression of ATP1A2 mRNA CTD PMID:22100608 all-trans-retinoic acid decreases expression ISO RGD:736008 6480464 Tretinoin results in decreased expression of ATP1A2 mRNA CTD PMID:21934132 amiodarone decreases expression EXP 6480464 Amiodarone results in decreased expression of ATP1A2 mRNA, Amiodarone results in decreased expression of ATP1A2 protein CTD PMID:12479229 more ... ammonia multiple interactions ISO RGD:10206 6480464 4-amino-5-4-methylphenyl-7-tert-butylpyrazolo3 more ... CTD PMID:20447429 ammonia increases expression ISO RGD:10206 6480464 Ammonia results in increased expression of ATP1A2 mRNA, Ammonia results in increased expression of ATP1A2 protein CTD PMID:20447429 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP1A2 mRNA CTD PMID:16483693 atrazine multiple interactions ISO RGD:10206 6480464 Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1A2 mRNA] CTD PMID:27112537 atrazine decreases expression ISO RGD:10206 6480464 Atrazine results in decreased expression of ATP1A2 mRNA CTD PMID:27112537 benzo[a]pyrene increases expression ISO RGD:736008 6480464 Benzoapyrene results in increased expression of ATP1A2 mRNA CTD PMID:20106945 benzo[a]pyrene decreases expression ISO RGD:736008 6480464 Benzoapyrene results in decreased expression of ATP1A2 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:736008 6480464 Benzoapyrene results in increased methylation of ATP1A2 exon, Benzoapyrene results in increased methylation of ATP1A2 promoter CTD PMID:27901495 benzo[e]pyrene decreases methylation ISO RGD:736008 6480464 benzoepyrene results in decreased methylation of ATP1A2 exon CTD PMID:30157460 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:736008 6480464 Diethylhexyl Phthalate results in decreased expression of ATP1A2 mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:736008 6480464 bisphenol A affects the expression of ATP1A2 mRNA CTD PMID:20170705 bisphenol A increases expression ISO RGD:10206 6480464 bisphenol A results in increased expression of ATP1A2 mRNA CTD PMID:30951980 bisphenol A increases methylation ISO RGD:10206 6480464 bisphenol A results in increased methylation of ATP1A2 promoter CTD PMID:27312807 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP1A2 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol F increases expression ISO RGD:10206 6480464 bisphenol F results in increased expression of ATP1A2 mRNA CTD PMID:30951980 calcitriol increases expression ISO RGD:736008 6480464 Calcitriol results in increased expression of ATP1A2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:736008 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ATP1A2 mRNA CTD PMID:21592394 captan decreases expression ISO RGD:10206 6480464 Captan results in decreased expression of ATP1A2 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:736008 6480464 Carbamazepine affects the expression of ATP1A2 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:10206 6480464 Nanotubes more ... CTD PMID:25554681 choline multiple interactions ISO RGD:10206 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP1A2 mRNA CTD PMID:20938992 cisplatin affects expression ISO RGD:736008 6480464 Cisplatin affects the expression of ATP1A2 mRNA CTD PMID:23300844 clothianidin decreases expression ISO RGD:736008 6480464 clothianidin results in decreased expression of ATP1A2 mRNA CTD PMID:29044138 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ATP1A2 mRNA CTD PMID:24386269 copper atom increases expression EXP 6480464 Copper results in increased expression of ATP1A2 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of ATP1A2 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:736008 6480464 Copper Sulfate results in decreased expression of ATP1A2 mRNA CTD PMID:19549813 daunorubicin decreases expression ISO RGD:736008 6480464 Daunorubicin results in decreased expression of ATP1A2 mRNA CTD PMID:26537877 , PMID:28940058 dexamethasone multiple interactions ISO RGD:736008 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ATP1A2 mRNA CTD PMID:28628672 dibenz[a,h]anthracene increases expression ISO RGD:10206 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:10206 6480464 Dibutyl Phthalate results in increased expression of ATP1A2 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:10206 6480464 Dibutyl Phthalate results in decreased expression of ATP1A2 mRNA CTD PMID:21266533 dichloroacetic acid decreases expression ISO RGD:10206 6480464 Dichloroacetic Acid results in decreased expression of ATP1A2 mRNA CTD PMID:28962523 digoxin decreases expression EXP 6480464 Digoxin results in decreased expression of ATP1A2 mRNA CTD PMID:19687166 digoxin multiple interactions EXP 6480464 N-2-methyl-4, 5-bismethylsulfonylbenzoylguanidine inhibits the reaction [Digoxin results in decreased expression of ATP1A2 mRNA] CTD PMID:19687166 dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of ATP1A2 mRNA CTD PMID:22193206 dioxygen multiple interactions ISO RGD:10206 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP1A2 mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ATP1A2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:736008 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ATP1A2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:736008 6480464 Doxorubicin results in decreased expression of ATP1A2 mRNA CTD PMID:26537877 more ... enalapril increases expression EXP 6480464 Enalapril results in increased expression of ATP1A2 mRNA, Enalapril results in increased expression of ATP1A2 protein CTD PMID:18418421 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ATP1A2 mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:10206 6480464 Ethanol affects the expression of and affects the splicing of ATP1A2 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:10206 6480464 Ethanol results in increased expression of ATP1A2 mRNA CTD PMID:30319688 etoposide decreases expression ISO RGD:736008 6480464 Etoposide results in decreased expression of ATP1A2 mRNA CTD PMID:29397400 folic acid multiple interactions ISO RGD:10206 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP1A2 mRNA CTD PMID:20938992 gamma-tocopherol increases expression ISO RGD:10206 6480464 Tocopherols results in increased expression of ATP1A2 mRNA CTD PMID:17654050 genistein decreases expression ISO RGD:736008 6480464 Genistein results in decreased expression of ATP1A2 mRNA CTD PMID:26865667 indometacin multiple interactions ISO RGD:736008 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ATP1A2 mRNA CTD PMID:28628672 ketamine increases expression EXP 6480464 Ketamine results in increased expression of ATP1A2 mRNA CTD PMID:20080153 L-methionine multiple interactions ISO RGD:10206 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP1A2 mRNA CTD PMID:20938992 lithium atom multiple interactions ISO RGD:736008 6480464 Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A2 mRNA] CTD PMID:19995221 lithium hydride multiple interactions ISO RGD:736008 6480464 Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A2 mRNA] CTD PMID:19995221 losartan increases expression EXP 6480464 Losartan results in increased expression of ATP1A2 mRNA, Losartan results in increased expression of ATP1A2 protein CTD PMID:18418421 lycopene multiple interactions ISO RGD:10206 6480464 Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1A2 mRNA] CTD PMID:27112537 mechlorethamine decreases expression ISO RGD:10206 6480464 Mechlorethamine results in decreased expression of ATP1A2 mRNA CTD PMID:17107856 metformin decreases expression EXP 6480464 Metformin results in decreased expression of ATP1A2 mRNA CTD PMID:31324951 methapyrilene decreases methylation ISO RGD:736008 6480464 Methapyrilene results in decreased methylation of ATP1A2 exon CTD PMID:30157460 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of ATP1A2 mRNA CTD PMID:21782745 methylene blue multiple interactions ISO RGD:10206 6480464 Methylene Blue inhibits the reaction [Sodium Cyanide results in increased phosphorylation of ATP1A2 protein] CTD PMID:31173149 methylmercury chloride decreases expression ISO RGD:736008 6480464 methylmercuric chloride results in decreased expression of ATP1A2 mRNA CTD PMID:28001369 mitoxantrone decreases expression ISO RGD:736008 6480464 Mitoxantrone results in decreased expression of ATP1A2 mRNA CTD PMID:26537877 , PMID:28940058 nickel atom decreases expression ISO RGD:736008 6480464 Nickel results in decreased expression of ATP1A2 mRNA CTD PMID:24768652 , PMID:25583101 ouabain multiple interactions ISO RGD:736008 6480464 Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A2 mRNA] CTD PMID:19995221 ouabain increases expression EXP 6480464 Ouabain results in increased expression of ATP1A2 protein CTD PMID:16716361 , PMID:19897708 ouabain decreases expression EXP 6480464 Ouabain results in decreased expression of ATP1A2 mRNA CTD PMID:19687166 ouabain affects expression EXP 6480464 Ouabain affects the expression of ATP1A2 protein CTD PMID:11834625 ouabain multiple interactions EXP 6480464 N-2-methyl-4, 5-bismethylsulfonylbenzoylguanidine inhibits the reaction [Ouabain results in decreased expression of ATP1A2 mRNA] CTD PMID:19687166 ouabain decreases activity ISO RGD:10206 6480464 Ouabain results in decreased activity of ATP1A2 protein CTD PMID:16166162 ouabain multiple interactions ISO RGD:10206 6480464 Ouabain binds to and results in decreased activity of ATP1A2 protein CTD PMID:18487447 ouabain affects response to substance ISO RGD:10206 6480464 ATP1A2 protein affects the susceptibility to Ouabain CTD PMID:15458945 , PMID:16166162 ouabain increases expression ISO RGD:736008 6480464 Ouabain results in increased expression of ATP1A2 mRNA CTD PMID:19995221 ouabain affects binding ISO RGD:736008 6480464 Ouabain binds to ATP1A2 protein CTD PMID:12479229 paracetamol decreases expression ISO RGD:736008 6480464 Acetaminophen results in decreased expression of ATP1A2 mRNA CTD PMID:29067470 paraquat affects expression EXP 6480464 Paraquat affects the expression of ATP1A2 mRNA CTD PMID:16854511 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ATP1A2 mRNA CTD PMID:18198484 paraquat decreases expression ISO RGD:10206 6480464 Paraquat results in decreased expression of ATP1A2 mRNA CTD PMID:21371552 paraquat increases expression ISO RGD:10206 6480464 Paraquat results in increased expression of ATP1A2 mRNA CTD PMID:21371552 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of ATP1A2 mRNA CTD PMID:17077588 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 perfluorononanoic acid decreases expression ISO RGD:736008 6480464 perfluorononanoic acid results in decreased expression of ATP1A2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of ATP1A2 mRNA CTD PMID:16221955 phenobarbital affects expression ISO RGD:736008 6480464 Phenobarbital affects the expression of ATP1A2 mRNA CTD PMID:19159669 pioglitazone multiple interactions ISO RGD:10206 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ATP1A2 mRNA CTD PMID:27935865 propanal increases expression ISO RGD:736008 6480464 propionaldehyde results in increased expression of ATP1A2 mRNA CTD PMID:26079696 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of ATP1A2 mRNA CTD PMID:28970091 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ATP1A2 mRNA CTD PMID:27900601 , PMID:28374803 SB 431542 multiple interactions ISO RGD:736008 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ATP1A2 mRNA CTD PMID:27188386 sodium cyanide multiple interactions ISO RGD:10206 6480464 [Sodium Cyanide results in increased activity of PRKCE protein] which results in increased phosphorylation of ATP1A2 protein, Methylene Blue inhibits the reaction [Sodium Cyanide results in increased phosphorylation of ATP1A2 protein] CTD PMID:31173149 sodium cyanide increases phosphorylation ISO RGD:10206 6480464 Sodium Cyanide results in increased phosphorylation of ATP1A2 protein CTD PMID:31173149 sunitinib decreases expression ISO RGD:736008 6480464 Sunitinib results in decreased expression of ATP1A2 mRNA CTD PMID:31533062 tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of ATP1A2 mRNA CTD PMID:28970091 testosterone multiple interactions ISO RGD:736008 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ATP1A2 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:736008 6480464 Testosterone results in increased expression of ATP1A2 mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ATP1A2 mRNA CTD PMID:12832660 tetradecane decreases expression EXP 6480464 n-tetradecane results in decreased expression of ATP1A2 protein CTD PMID:17337753 titanium dioxide decreases expression ISO RGD:10206 6480464 titanium dioxide results in decreased expression of ATP1A2 mRNA CTD PMID:23557971 tocopherol increases expression ISO RGD:10206 6480464 Tocopherols results in increased expression of ATP1A2 mRNA CTD PMID:17654050 trichostatin A increases expression ISO RGD:736008 6480464 trichostatin A results in increased expression of ATP1A2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:736008 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ATP1A2 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:736008 6480464 Triclosan results in decreased expression of ATP1A2 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:10206 6480464 trimellitic anhydride results in decreased expression of ATP1A2 mRNA CTD PMID:19042947 tyrphostin AG 1478 multiple interactions ISO RGD:10206 6480464 RTKI cpd inhibits the reaction [Ammonia results in increased expression of ATP1A2 mRNA], RTKI cpd inhibits the reaction [Ammonia results in increased expression of ATP1A2 protein] CTD PMID:20447429 undecane increases expression EXP 6480464 undecane results in increased expression of ATP1A2 protein CTD PMID:17337753 valproic acid decreases expression ISO RGD:736008 6480464 Valproic Acid results in decreased expression of ATP1A2 mRNA CTD PMID:23179753 more ... valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of ATP1A2 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:736008 6480464 Valproic Acid results in increased expression of ATP1A2 mRNA CTD PMID:24935251 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ATP1A2 mRNA CTD PMID:23034163 XL147 multiple interactions ISO RGD:10206 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ATP1A2 mRNA CTD PMID:27935865